Pfizer looking to become first company with approved COVID-19 vaccine for kids aged 5 to 11.
Pfizer has asked Health Canada to approve use of its vaccine on kids between the ages of 5 and 11.
If given the go-ahead, it'll be the first shot available to children in Canada, but new child-sized doses will need to be made available.
The vaccine was a team effort with Germany's BioNTech, and the doses are about one-third the size of that given to people 12 and older.
The company completed a clinical trial for its child-size dose, and the data was submitted to Health Canada earlier this month.
As well, a formal request for approval was made last week to the U.S. Food and Drug Administration.
City Encouraged to Go After Funding
Cost of Renewing Vows Could Rise
GM Investing in St. Catharines
NRP Investigating Fatal Pelham Crash
NRP Officers Praised by Management
945 Supportive Housing Units Approved
Niagara Talks Canadian Defense
Niagara Falls Expecting More Evacuees